1977
DOI: 10.1118/1.594365
|View full text |Cite
|
Sign up to set email alerts
|

Proton penetration and control in nonhomogeneous phantoms

Abstract: Accurate bolus is needed for extension of Bragg-peak therapy. Proton beam-stopping profiles in a lucite-styrofoam-tissue phantom and in a Rando phantom were recorded photographically. Air volumes caused the largest distortions. Lucite bolus was cut to achieve desired beam-stopping profiles. Verification of bolus effect in situ will be important to control beam penetration within 5 mm.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
6
0

Year Published

1984
1984
2018
2018

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 0 publications
0
6
0
Order By: Relevance
“…In particular, the finite range of a proton beam may be adjusted such that the therapeutic dose vanishes beyond the tumor. The proton range, which is commonly expressed in terms of its equivalent range in liquid water, may be precisely controlled by the accelerator (Coutrakon et al 1997), energy degrader system (Jongen et al 1996), a range shifter in the treatment head (Newhauser et al 2007b) and a range compensator (Wingate et al 1977, Fontenot et al 2007). …”
Section: Introductionmentioning
confidence: 99%
“…In particular, the finite range of a proton beam may be adjusted such that the therapeutic dose vanishes beyond the tumor. The proton range, which is commonly expressed in terms of its equivalent range in liquid water, may be precisely controlled by the accelerator (Coutrakon et al 1997), energy degrader system (Jongen et al 1996), a range shifter in the treatment head (Newhauser et al 2007b) and a range compensator (Wingate et al 1977, Fontenot et al 2007). …”
Section: Introductionmentioning
confidence: 99%
“…Range compensators are designed to spare normal tissue just distal to the target from unwanted dose by adjusting the penetration of the proton beam to account for the shape of the target, patient surface, and heterogeneities within the patient. [8][9][10][11] Standardized methods for measuring the absorbed dose in clinical proton beams-critical for ensuring accuracy and consistency in dose reporting-have not yet been fully established. Traditionally, clinical D / MU values have been determined by measuring dose in a water or plastic phantom, [12][13][14] a relatively simple but labor-intensive approach.…”
Section: Introductionmentioning
confidence: 99%
“…Using this technique, a narrow, nearly monoenergetic, proton beam is transformed to a clinically useful size by using scattering foils to laterally spread and flatten the beam and a range modulator wheel to increase the width of the Bragg peak [79]. The final components that the beam pass through are patient-specific devices, consisting of an aperture to collimate the field, and a range compensator to distally shape the beam [1013]. A challenge that arises from use of the passive scattering proton beam delivery technique is the determination of beam output that is needed to deliver a prescribed dose, namely, calibrating the dose per monitor unit (DMU).…”
Section: Introductionmentioning
confidence: 99%